GDF-15 Inhibits ADP-Induced Human Platelet Aggregation through the GFRAL/RET Signaling Complex

Biomolecules. 2023 Dec 27;14(1):38. doi: 10.3390/biom14010038.

Abstract

Growth differentiation factor-15 (GDF-15) is proposed to be strongly associated with several cardiovascular diseases, such as heart failure and atherosclerosis. Moreover, some recent studies have reported an association between GDF-15 and platelet activation. In this study, we isolated peripheral blood platelets from healthy volunteers and evaluated the effect of GDF-15 on adenosine diphosphate (ADP)-induced platelet activation using the platelet aggregation assay. Subsequently, we detected the expression of GDF-15-related receptors on platelets, including the epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), human epidermal growth factor receptor 3 (HER3), transforming growth factor-beta receptor I (TGF-βRI), transforming growth factor-beta receptor II (TGF-βRII), glial-cell-line-derived neurotrophic factor family receptor α-like (GFRAL), and those rearranged during transfection (RET). Then, we screened for GDF-15 receptors using the GDF-15-related receptor microarray comprising these recombinant proteins. We also performed the immunoprecipitation assay to investigate the interaction between GDF-15 and the receptors on platelets. For the further exploration of signaling pathways, we investigated the effects of GDF-15 on the extracellular signal-regulated kinase (ERK), protein kinase B (AKT), and Janus kinase 2 (JAK2) pathways. We also investigated the effects of GDF-15 on the ERK and AKT pathways and platelet aggregation in the presence or absence of RET agonists or inhibition. Our study revealed that GDF-15 can dose-independently inhibit ADP-induced human platelet aggregation and that the binding partner of GDF-15 on platelets is GFRAL. We also found that GDF-15 inhibits ADP-induced AKT and ERK activation in platelets. Meanwhile, our results revealed that the inhibitory effects of GDF-15 can be mediated by the GFRAL/RET complex. These findings reveal the novel inhibitory mechanism of ADP-induced platelet activation by GDF-15.

Keywords: extracellular signal-regulated kinase; glial-cell-line-derived neurotrophic factor family receptor α-like; growth differentiation factor-15; platelet; protein kinase B.

MeSH terms

  • Adenosine Diphosphate / pharmacology
  • ErbB Receptors
  • Extracellular Signal-Regulated MAP Kinases
  • Glial Cell Line-Derived Neurotrophic Factor Receptors* / metabolism
  • Growth Differentiation Factor 15* / pharmacology
  • Humans
  • Platelet Aggregation* / genetics
  • Proto-Oncogene Proteins c-akt
  • Proto-Oncogene Proteins c-ret*
  • Transforming Growth Factors

Substances

  • Adenosine Diphosphate
  • ErbB Receptors
  • Extracellular Signal-Regulated MAP Kinases
  • Growth Differentiation Factor 15
  • Proto-Oncogene Proteins c-akt
  • Proto-Oncogene Proteins c-ret
  • RET protein, human
  • Transforming Growth Factors
  • Glial Cell Line-Derived Neurotrophic Factor Receptors